Saral Advanced Diagnostic Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
as on 23-12-2024
- Paid Up Capital ₹ 9.25 M
as on 23-12-2024
- Company Age 26 Year, 3 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 21.09 Cr
as on 23-12-2024
- Revenue 51.01%
(FY 2022)
- Profit 372.84%
(FY 2022)
- Ebitda 121.29%
(FY 2022)
- Net Worth 83.77%
(FY 2022)
- Total Assets -11.28%
(FY 2022)
About Saral Advanced Diagnostic
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 9.25 M.
The company currently has active open charges totaling ₹21.09 Cr.
Kamal Trehan, Vijay Giridher, and Ravi Gupta serve as directors at the Company.
- CIN/LLPIN
U85110DL1998PTC096130
- Company No.
096130
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
09 Sep 1998
- Date of AGM
13 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Saral Advanced Diagnostic?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Kamal Trehan  | Director | 09-Sep-1998 | Current |
| Vijay Giridher | Director | 20-Mar-2008 | Current |
| Ravi Gupta | Director | 09-Sep-1998 | Current |
Financial Performance of Saral Advanced Diagnostic.
Saral Advanced Diagnostic Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 51.01% increase. The company also saw a substantial improvement in profitability, with a 372.84% increase in profit. The company's net worth Soared by an impressive increase of 83.77%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Saral Advanced Diagnostic?
Unlock access to Saral Advanced Diagnostic's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Saral Diagnostics Classic Private LimitedActive 7 years 7 monthsKamal Trehan, Vijay Giridher and 1 more are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 26 Dec 2023 | ₹9.54 Cr | Open |
Yes Bank Limited Creation Date: 14 Dec 2018 | ₹3.29 Cr | Open |
Hdfc Bank Limited Creation Date: 16 Aug 2017 | ₹4.95 Cr | Open |
How Many Employees Work at Saral Advanced Diagnostic?
Saral Advanced Diagnostic has a workforce of 8 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Saral Advanced Diagnostic, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Saral Advanced Diagnostic's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
